Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 11/20 | 0.48 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | INPP5B | P32019 | 2/20 | 0.44 |
| ▸ | SRC | P12931 | 5/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10751352 | 0.97 | INPPL1 (0.46) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL28505708 | 0.85 | INPPL1 (0.41) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL554860 | 0.80 | FDPS (0.39) | INPPL1INPP5AAKT1INPP5BFDPS | |
| SCHEMBL14956572 | 0.79 | FDPS (0.38) | INPPL1INPP5AAKT1INPP5BFDPS | |
| SCHEMBL4181314 | 0.78 | INPPL1 (0.60) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL6273605 | 0.77 | CA1 (0.36) | CA1CA2CA9 | |
| SCHEMBL28983527 | 0.75 | INPPL1 (0.41) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL10942731 | 0.75 | INPPL1 (0.41) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL11334192 | 0.74 | CA1 (0.35) | CA1CA2CA9 | |
| SCHEMBL9538185 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1963536-A2 | POLYMERASES FOR NUCLEOTIDE ANALOGUE INCORPORATION | Pacific Biosciences of California, Inc. (US) | 2008-09-03 | — | — | EP | claimed |
| US-20070196846-A1 | Polymerases for nucleotide analogue incorporation | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2007-08-23 | — | — | US | claimed |
| WO-2007076057-A2 | POLYMERASES FOR NUCLEOTIDE ANALOGUE INCORPORATION | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2007-07-05 | — | — | WO | claimed |
| CN-86104458-A | With affinity chromatography purifying haemachrome and improvement haemachrome | — | 1987-07-01 | — | — | CN | claimed |
| US-20240215624-A1 | PROCESSED DAIRY-TYPE FOOD PRODUCTS | BK GIULINI GMBH (DE) | 2024-07-04 | — | — | US | disclosed |
| EP-4262414-A1 | PROCESSED DAIRY-TYPE FOOD PRODUCTS | BK Giulini GmbH (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-20230176481-A1 | FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-08 | — | — | US | disclosed |
| WO-2022129525-A1 | PROCESSED DAIRY-TYPE FOOD PRODUCTS | BK GIULINI GMBH (DE) | 2022-06-23 | — | — | WO | disclosed |
| EP-3056575-A1 | POLYMERASES FOR NUCLEOTIDE ANALOGUE INCORPORATION | Pacific Biosciences Of California, Inc. (US) | 2016-08-17 | — | — | EP | disclosed |
| US-9133231-B2 | Compounds for treating bacterial infections | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-09-15 | — | — | US | disclosed |
| US-20130203694-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-08-08 | — | — | US | disclosed |
| EP-2601205-A2 | GUANINE NUCLEOTIDE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) | 2013-06-12 | — | — | EP | disclosed |
| US-20030155123-A1 | Method of treating reservoir zone of hydrocarbon producing well to inhibit water production problerms | STATOIL ASA (NO) | 2003-08-21 | — | — | US | disclosed |
| EP-1257727-A1 | METHOD OF TREATING RESERVOIR ZONE OF HYDROCARBON PRODUCING WELL TO INHIBIT WATER PRODUCTION PROBLEMS | Statoil ASA (NO) | 2002-11-20 | — | — | EP | disclosed |
| WO-2001059255-A1 | METHOD OF TREATING RESERVOIR ZONE OF HYDROCARBON PRODUCING WELL TO INHIBIT WATER PRODUCTION PROBLEMS | STATOIL ASA (NO) | 2001-08-16 | — | — | WO | disclosed |
| CN-1173220-A | Methods and packaging designs for cryopreservation and storage of cultured tissue equivalents | ORGANOGENESIS INC (US) | 1998-02-11 | — | — | CN | disclosed |
| US-5656541-A | HEATING A RARE EARTH OXIDE AND PHOSPHORIC ACID TO FORM A MIXED OXIDE COMPOUND, FIRING TO EVOLVE PHOSPHORUS OXIDE TO DEPOSIT A GLASSY COATING OF SPECIFIED THICKNESS ON A SILICON WAFER | TECHNEGLAS, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| US-5350461-A | Semiconductors | TECHNEGLAS, INC. (US) | 1994-09-27 | — | — | US | disclosed |
| EP-0022757-B1 | METHOD FOR DETERMINING CREATINE KINASE IN SAMPLES CONTAINING ATP | LKB-Produkter AB (SE) | 1984-09-19 | — | — | EP | disclosed |
| EP-0022757-A1 | Method for determining creatine kinase in samples containing ATP | LKB-Produkter AB (SE) | 1981-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196846-A1 | Polymerases for nucleotide analogue incorporation | POLN, POLB, POLM | INPPL1 445/4885INPP5A 459/4885AKT1 2496/4885 |
| US-20130203694-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | REL, RELA, RRP1B | INPPL1 2573/4885INPP5A 1906/4885AKT1 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.